Compass Therapeutics, Inc.
CMPX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,259 | -$19,881 | -$16,633 | -$15,033 |
| Dep. & Amort. | $19 | -$226 | $364 | $359 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $1,238 | $2,791 | $2,514 | $2,238 |
| Change in WC | $0 | $5,019 | $521 | $3,544 |
| Other Non-Cash | $0 | $465 | $26 | -$270 |
| Operating Cash Flow | $0 | -$11,832 | -$13,208 | -$9,162 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$18 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$109,077 | -$33,173 | -$24,832 | -$9,861 |
| Inv. Sales/Matur. | $13,928 | $26,813 | $36,438 | $25,231 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$95,156 | -$6,360 | $11,588 | $15,370 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | -$815 | -$94 |
| Financing Cash Flow | $129,361 | $0 | -$815 | -$94 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $23,356 | -$18,192 | -$2,435 | $6,114 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $0 | $41,616 | $44,051 | $37,369 |
| End Cash | $23,356 | $23,424 | $41,616 | $43,483 |
| Free Cash Flow | $0 | -$11,832 | -$13,226 | -$9,162 |